Director of the Barcelona Institute of Science and Technology (BIST) and the Institute of Chemical Research of Catalonia (ICIQ)
Since October 2016, Dr. Pericàs has combined his position as director of the ICIQ with the responsibility of heading up BIST. Before taking on the role as director of the ICIQ in 2000, he was a professor of Organic Chemistry at the University of Barcelona. Pericàs’s research career focused on chemistry and has received Catalan government's Distinction for the Promotion of University Research, the Janssen-Cylag Award from the Spanish Royal Society of Chemistry and the Narcís Monturiol Medal from the Government of Catalonia.
Senior Advisor and former Head of Business Development at the Wellcome Trust
Dr. Seabrook, PhD, MBA served as Head of Business Development at the Wellcome Trust, responsible for intellectual property management and its transfer, through licensing or new company formation. Seabrook also led the Technology Transfer Division, which aims to add value to basic scientific findings when they can be developed into products. This division reduces the risk, the proof of concept, and makes it attractive to follow-on investors (licensing perspective or financial community).
Director of MaRS EXCITE program at MaRS Discovery District, Health System Innovation
Khayat works to get healthcare systems to adopt the best technology to improve public health and performance, as well as promoting the new economy of health. She is also an adjunct professor in the Health Sector Strategy stream at the University of Toronto Rotman School of Management. She has 11 years of experience in strategic consulting in the healthcare and life sciences sector.
Former President and CEO of Massachussetts Life Sciences Center
A world-renowned expert in innovation, she has been called one of the "10 most influential women in biotech" by the Boston Globe and one of the "50 most powerful women in Boston" by Boston Magazine. She is managing partner at Biomedical Innovation Advisors and also President and CEO of Biomedical Growth Strategies. She has been president and CEO of the Massachusetts Life Sciences Center (MLC).
Michael Müller founded Cepton Strategies, a company that in 2014 sold the Boston's firm CRA. German financial newspaper Capital has called his company the leading strategic consultancy in healthcare, ahead of McKinsey, Boston Consulting Group and Roland Berger. Müller has led numerous projects involving private equity companies, healthcare groups and investment funds and is an expert in corporate strategy with extensive experience in business development, R&D and M&A.
Venture Partner at Draper Esprit and Chairman of the Digital Health Forum
Dr. Vishal Gulati is one of Europe's leading digital healthcare investors and a venture partner at DFJ Esprit, a firm specializing in digital health that follows the style set by Silicon Valley. He has become a renowned promoter of investment in the emerging digital health sector and presides over the Digital Health Forum. Gulati has more than a decade of experience in VC. He is on the Board of Directors at Horizon Discovery PLC and EcoEos.